Crispr Therapeutics shares owned by Vigilant Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Vigilant Capital Management
from 13F filings
Historical chart of Vigilant Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Vigilant Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Vigilant Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-06-30 | $17k | 300 | 56.67 |
| 2023-03-31 | $14k | 300 | 46.67 |
| 2022-12-31 | $12k | 300 | 40.00 |
| 2022-09-30 | $51k | 773 | 65.98 |
| 2022-06-30 | $47k | 773 | 60.80 |
| 2022-03-31 | $49k | 773 | 63.39 |
| 2021-12-31 | $59k | 773 | 76.33 |
| 2021-09-30 | $87k | 773 | 112.55 |
| 2021-06-30 | $125k | 773 | 161.71 |
| 2021-03-31 | $94k | 773 | 121.60 |
| 2020-12-31 | $46k | 300 | 153.33 |
| 2020-09-30 | $25k | 300 | 83.33 |
More positions owned by Vigilant Capital Management
View all positions for Vigilant Capital Management